{Reference Type}: Case Reports
{Title}: Takotsubo syndrome as an acute cardiac complication following combined chemotherapy.
{Author}: Nati-Castillo HA;Aristizabal-Colorado D;López Ordoñez C;Egas Proaño D;Ortiz-Prado E;Izquierdo-Condoy JS;
{Journal}: Int J Cardiol Cardiovasc Risk Prev
{Volume}: 22
{Issue}: 0
{Year}: 2024 Sep
暂无{DOI}: 10.1016/j.ijcrp.2024.200292
{Abstract}: <B>UNASSIGNED: </B>Acute cardiac complications post-chemotherapy is rare. Stress cardiomyopathy, one of these complications, should be considered in differential diagnoses as its symptoms closely resemble those of acute myocardial infarction and can lead to mortality.<BR><B>UNASSIGNED: </B>The objective of this paper is to describe Takotsubo syndrome (TTS) as an acute complication following combined chemotherapy in a patient with significant thromboembolic burden and metastatic cervical cancer.<BR><B>UNASSIGNED: </B>A 61-year-old female patient with a diagnosis of metastatic cervical cancer experienced acute chest pain. Elevated troponin levels and abnormalities in the electrocardiogram initially suggested an acute myocardial infarction, occurring after a chemotherapy session involving Carboplatin and Paclitaxel infusion. Although initial treatment targeted myocardial infarction, further diagnostic evaluations including coronary angiography and cardiac magnetic resonance imaging revealed no coronary artery disease but identified features consistent with stress cardiomyopathy, indicative of Takotsubo syndrome (TTS). This diagnosis led to an improvement in symptoms and a resolution of the acute changes observed.<BR><B>UNASSIGNED: </B>Stress cardiomyopathy, particularly TTS, is being increasingly recognized as an acute complication associated with combined chemotherapy regimens. The potential cardiotoxic effects of these chemotherapy agents demand careful monitoring and evaluation in patients undergoing oncological treatment, underscoring the importance of integrating cardioprotective strategies into the management of these patients.